Exposure of intensive care unit nurses to nitric oxide and nitrogen dioxide during therapeutic use of inhaled nitric oxide in adults with acute respiratory distress syndrome

American Journal of Critical Care

Volumn 12, Issue 2, 2003, Pages 147-153

  Qureshi, Mohammed A ^a   Shah, Nipurn J ^a   Hemmen, Carol W ^a   Thill, Mary C ^a   Kruse, James A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITROGEN DIOXIDE;

ADULT RESPIRATORY DISTRESS SYNDROME; AIR POLLUTANT; ARTICLE; ENVIRONMENTAL MONITORING; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE UNIT; NURSING; OCCUPATIONAL EXPOSURE;

ADMINISTRATION, INHALATION; AIR POLLUTANTS, OCCUPATIONAL; ENVIRONMENTAL MONITORING; HUMANS; INTENSIVE CARE UNITS; NITRIC OXIDE; NITROGEN DIOXIDE; OCCUPATIONAL EXPOSURE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0037945741     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2003.12.2.147     Document Type: Article

References (56)

1. Beard RR. Inorganic compounds of oxygen, nitrogen, and carbon. In: Clayton GD, Clayton FE, eds. Patty's Industrial Hygiene and Toxicology. 3rd ed. Vol. 2C. New York, NY: John Wiley & Sons; 1982:4053-4139.
2. Documentation of the Threshold Limit Values for Chemical Substances in the Workroom Environment. 4th ed. Cincinnati, Ohio: American Conference of Governmental Industrial Hygienists Inc; 1980.
3. Budavari S, O'Neil MJ, Smith A, Heckelman PE, Kinneary JF, eds. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals. 12th ed. Whitehouse Station, NJ: Merck; 1996:1131.
4. Sittig M. Handbook of Toxic and Hazardous Chemicals and Carcinogens. 3rd ed. Park Ridge, NJ: Noyes Publications; 1991:1201-1203, 1217-1219.
5. Lipsett M. Oxides of nitrogen and sulfur. In: Sullivan JB Jr, Krieger GR, eds. Hazardous Materials Toxicology: Clinical Principles of Environmental Health. Baltimore, Md: Williams & Wilkins; 1992:964-972.
6. Clayton GD. Air pollution. In: Clayton GD, Clayton FE, eds. Patty's Industrial Hygiene and Toxicology. 4th ed. New York, NY: John Wiley & Sons; 1991:195-258.
7. Lipsett MJ, Shusterman DJ, Beard RR. Inorganic compounds of carbon, nitrogen, and oxygen. In: Clayton GD, Clayton FE, eds. Patty's Industrial Hygiene and Toxicology. New York, NY: John Wiley & Sons; 1994: 4523-4643.
8. Modrak JE, Frampton MW, Utell MJ. Community air pollution: what a pulmonologist should know. Clin Pulm Med. 1997;4:266-272.
9. Samet JM, Marbury MC, Spengler JD. Health effects and sources of indoor air pollution: part I. Am Rev Respir Dis. 1987;136:1486-1508.
10. Occupational Safety and Health Administration, US Department of Labor. OSHA Regulated Hazardous Substances: Health, Toxicity, Economic and Technological Data. Vol. 2. Park Ridge, NJ: Noyes Data Corp; 1990:1419-1421, 1437-1440.
11. Krafft P, Metnitz PGH, Fridrich P, Krenn CG, Hammerle AF, Steltzer H. Impact of inhaled nitric oxide on cardiopulmonary performance and outcome of ARDS patients: a literature review. Clin Intensive Care. 1997;8:27-32.
12. Dellinger RP, Zimmerman JL, Taylor RW, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med. 1998;26:15-23.
13. Michael JR, Barton RG, Saffle JR, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med. 1998;157:1372-1380.
14. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in fullterm and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 1997;336:597-604.
15. Okamoto K, Hamaguchi M, Kukita I, Kikuta K, Sato T. Efficacy of inhaled nitric oxide in children with ARDS. Chest. 1998;114:827-833.
16. Johannigman JA, Davis K Jr, Campbell RS, Luchette F, Hurst JM, Branson RD. Inhaled nitric oxide in acute respiratory distress syndrome. J Trauma. 1997;43:904-909.
17. Johannigman JA, Davis K Jr, Miller SL, et al. Prone positioning and inhaled nitric oxide: synergistic therapies for acute respiratory distress syndrome. J Trauma. 2001;50:589-595.
18. Gerlach H, Rossaint R, Pappert D, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest. 1993;23:499-502.
19. Young JD, Dyar OJ. Delivery and monitoring of inhaled nitric oxide. Intensive Care Med. 1996;22:77-86.
20. Cuthbertson BH, Galley HF, Webster NR. Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury. Crit Care Med. 2000;28:1736-1741.
21. Hoehn T, Krause MF. Response to inhaled nitric oxide in premature and term neonates. Drugs. 2001;61:27-39.
22. Tworetzky W, Bristow J, Moore P, et al. Inhaled nitric oxide in neonates with persistent pulmonary hypertension [letter]. Lancet. 2001;357:118-120.
23. Journois D, Pouard P, Mauriat P, Malhère T, Vouhé P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operation for congenital heart defects. J Thorac Cardiovasc Surg. 1994;107:1129-1135.
24. Gothberg S, Edberg KE. Inhaled nitric oxide to newborns and infants after congenital heart surgery on cardiopulmonary bypass: a dose-response study. Scand Cardiovasc J. 2000;34:154-158.
25. Solina AR, Ginsberg SH, Papp D, et al. Dose response to nitric oxide in adult cardiac surgery patients. J Clin Anesth. 2001;13:281-286.
26. Ardehali A, Hughes K, Sadeghi A, et al. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation. 2001;72:638-641.
27. Ardehali A, Laks H, Levine M, et al. A prospective trial of inhaled nitric oxide in clinical lung transplantation. Transplantation. 2001;72:112-115.
28. Crerar-Gilbert A, Boots R. Use of inhaled nitric oxide in pulmonary embolism. Anaesth Intensive Care. 1999;27:412-414.
29. Gladwin MT, Schechter AN, Shelhamer JH, et al. Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity. J Clin Invest. 1999;104:937-945.
30. Rabkin DG, Sladen RN, DeMango A, Steinglass KM, Goldstein DJ. Nitric oxide for the treatment of postpneumonectomy pulmonary edema. Ann Thorac Surg. 2001;72:272-274.
31. Nakagawa TA, Johnston SJ, Falkos SA, Gomez RJ, Morris A. Life-threatening status asthmaticus treated with inhaled nitric oxide. J Pediatr. 2000;137:119-122.
32. Perez-Penate G, Julia-Serda G, Pulido-Duque JM, Gorriz-Gomez E, Cabrera-Navarro P. One-year continuous inhaled nitric oxide for primary pulmonary hypertension. Chest. 2001;119:970-973.
33. Jones C. Inhaled nitric oxide: are the safety issues being addressed? Intensive Crit Care Nurs. 1998;14:271-275.
34. Goldman AP, Cook PD, Macrae DJ. Exposure of intensive-care staff to nitric oxide and nitrogen dioxide [letter]. Lancet. 1995;345:923-924.
35. Kalweit S. Inhaled nitric oxide in the ICU. Crit Care Nurse. August 1997;17:26-32.
36. Bathe D, Berssenbrugge A, Kohlmann T, Montgomery F. Monitoring accuracy for the measurement of nitric oxide in the 0 to 80 ppm range [abstract]. Crit Care Med. 1996;24:A103.
37. Guidelines for Protecting the Safety and Health of Health Care Workers. Washington, DC: US Dept of Health and Human Services, National Institute for Occupational Safety and Health, Division of Standards Development and Technology Transfer; 1988:2-9. DHHS (NIOSH) publication 88-119.
38. Nitrogen dioxide and nitric oxide. In: Eller PM, Cassinelli ME, eds. NIOSH Manual of Analytical Methods. 4th ed. Washington, DC: US Dept of Health and Human Services, National Institute for Occupational Safety and Health, Division of Physical Sciences and Engineering; 1994:(6014)1-4. DHHS (NIOSH) publication 94-113.
39. Stuehr DJ, Griffith OW. Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol. 1992;65:287-346.
40. Kobzik L, Bredt DS, Lowenstein CJ, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol. 1993;9:371-377.
41. Gaston B, Drazen M, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med. 1994;149:538-551.
42. Greenbaum R, Bay J, Hargreaves MD, et al. Effects of higher oxides of nitrogen on the anaesthetized dog. Br J Anaesth. 1967;39:393-404.
43. Harris LR, Sarvadi DG. Synthetic polymers. In: Clayton GD, Clayton FE, eds. Patty's Industrial Hygiene and Toxicology. 4th ed. Vol. 2, part E. New York, NY: John Wiley & Sons; 1991:3673-4005.
44. Criteria for a Recommended Standard: Occupational Exposure to Oxides of Nitrogen (Nitrogen Dioxide and Nitric Oxide). Washington, DC: US Dept of Health and Human Services, National Institute for Occupational Safety and Health; 1976:2. DHHS (NIOSH) publication 76-149.
45. Hyde D, Orthoefer J, Dungworth D, Tyler W, Carter R, Lum H. Morphometric and morphologic evaluation of pulmonary lesions in beagle dogs chronically exposed to high ambient levels of air pollutants. Lab Invest. 1978;38:455-469.
46. Kagawa J. Respiratory effects of 2-hr exposure to 1.0 ppm nitric oxide in normal subjects. Environ Res. 1982;27:485-490.
47. Rasmussen TR, Kjaergaard SK, Tarp U, Pedersen OF. Delayed effects of NO2 exposure on alveolar permeability and glutathione peroxidase in healthy humans. Am Rev Respir Dis. 1992;146:654-659.
48. Tunnicliffe WS, Burge PS, Ayres JG. Effect of domestic concentrations of nitrogen dioxide on airway responses to inhaled allergen in asthmatic patients. Lancet. 1994;344:1733-1736.
49. Morrow PE, Utell MJ, Bauer MA, et al. Pulmonary performance of elderly normal subjects and subjects with chronic obstructive pulmonary disease exposed to 0.3 ppm nitrogen dioxide. Am Rev Respir Dis. 1992;145:291-300.
50. Mourgeon E, Levesque E, Duveau C, et al. Factors influencing indoor concentrations of nitric oxide in a Parisian intensive care unit. Am J Respir Crit Care Med. 1997;156:1692-1695.
51. Markhorst DG, Leenhoven T, Uiterwijk JW, Meulenbelt J, van Vught AJ. Occupational exposure during nitric oxide inhalational therapy in a pediatric intensive care setting. Intensive Care Med. 1996;22:954-958.
52. Phillips ML, Hall TA, Sekar K, Tomey JL. Assessment of medical personnel exposure to nitrogen oxides during inhaled nitric oxide treatment of neonatal and pediatric patients. Pediatrics. 1999;104:1095-1100.
53. Sixth Annual Report of the Council on Environmental Quality. Washington, DC: Environmental Protection Agency; 1975. Publication 040-000-00337-1.
54. Mourgeon E, Gallart L, Umamaheswara Rao GS, et al. Distribution of inhaled nitric oxide during sequential and continuous administration into the inspiratory limb of the ventilator. Intensive Care Med. 1997;23:849-858.
55. Losa M, Tibballs J, Carter B, Holt MP. Generation of nitrogen dioxide during nitric oxide therapy and mechanical ventilation of children with a Servo 900C ventilator. Intensive Care Med. 1997;23:450-455.
56. Guidelines for preventing transmission of Mycobacterium tuberculosis in health-care facilities. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1994;43(RR-13):1-132.